IDIBELL on the media

ImageJ=1.52p
unit=micron

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells

At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely used in biomedical research by hundreds of laboratories around the world, has approximately the same number of genes that humans have, about 20,000. […]

imagen_0

Innovation for value turns Barcelona into the world capital of health innovation

The event, co-organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), will take place on November 8 at the Bellvitge University Hospital

martin_freeman_benedict_cumberbatch

Researchers identify a neural mechanism involved in the creation and consolidation of memories

The study of the UB and IDIBELL showed brain patterns we generate when watching a film are similar, and follow the same order, than the patterns created when the story is narrated

nen_esquena

IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome

The project is led by Dr. Eulàlia Baselga, Area of Dermatology of the Hospital Sant Joan de Déu Barcelona, and Dr. Mariona Graupera, Bellvitge Biomedical Research Institute (IDIBELL). Its main objective is to identify a treatment aimed at reversing or improving the vascular alterations produced by the R183Q mutation in the GNAQ gene that leads to Sturge-Weber Syndrome.

imagen

Innovation for value, the first international innovation conference at IDIBELL

On November 8, IDIBELL and ITEMAS co-organize Innovation for Value (#I4V), a conference focusing on the opportunities offered by innovation and new technologies in the healthcare field. In this event, which will take place at the Bellvitge University Hospital, speakers will also analyze the new business opportunities that arise thanks to scientific innovation and the […]

antonella-consiglio

A medicine for prostatic hyperplasia could help slow the progression of Parkinson’s disease

Parkinson’s disease (PD) is an old age disorder that causes a series of motor deficiencies that are characteristic. Normally, the four main symptoms are hand tremor, limb stiffness, slowness and impaired balance. With the progression of the disease, patients may also experience dementia and other neurological disorders. Since the main symptoms are due to degeneration […]

bruna

Oligodendroglial brain tumor survivors run the risk of developing long-term cognitive impairment

Recent results highlight the need to develop future therapeutic strategies to minimize the adverse effects of cancer treatment in patients with brain tumors and prolonged expected survival

cropped-logo-final

The 2nd GRIN2B European Meeting brings together international experts and families suffering from this rare illness in Barcelona

The second GRIN2B European annual conference on GRINpathies, genetic defects of NMDA receptors, organized by the European Association GRIN2B, the group of Dr. Xavier Altafaj and collaborators of the Pompeu Fabra University and the Hospital Sant Joan de Déu, took place this past weekend. This meeting aims is to foster interactions between families, doctors and […]

foto_2

Researchers prove the usefulness of semen miRNAs as non-invasive biomarkers for prostate cancer

Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital (HUB), show the usefulness of certain molecules , the miRNAs in semen, as non-invasive biomarkers for prostate cancer. […]

efou6jzxoaaohib

David Llobet and Eva González Suárez receive AECC grants on World Cancer Research Day

The AECC has awarded 171 projects worth almost € 21M

Scroll to Top